Biotech

All Articles

Galapagos stops CAR-T cell treatment hearing over Parkinsonism case

.Galapagos has paused registration in a trial of a BCMA-directed CAR-T tissue therapy, pumping the b...

James Wilson leaving behind Penn to release 2 brand new biotechs

.After much more than 30 years, genetics treatment innovator James Wilson M.D., Ph.D., is leaving be...

3 biotechs try to defeat the summer season heat energy through losing team

.As biotechs seek to turn a new web page in August, at the very least three providers have actually ...

venBio elevates $528M for fifth lifestyle sciences VC fund

.Veteran financial backing firm venBio has raised one more half a billion dollars to buy biotechs de...

Otsuka spends $800M for Jnana as well as its clinical-stage PKU medication

.Otsuka Pharmaceutical has actually picked up Boston-based Jnana Rehabs for $800 thousand so the Jap...

FibroGen gives up 75% people staff as asset flunks 2 even more tests

.FibroGen is substantially reorganizing its own business, giving up 75% of its U.S. workers as well ...

Tracon wane full weeks after injectable PD-L1 prevention neglect

.Tracon Pharmaceuticals has actually decided to relax operations weeks after an injectable invulnera...

Ideaya bags alternative on Biocytogen bispecific ADC in $400M package

.Ideaya Biosciences is wagering $400 thousand in biobucks that a bispecific antibody-drug conjugate ...

Takeda takes $140M loss on neglected epilepsy medication, proclaims FDA manage

.Our team currently recognize that Takeda is expecting to locate a course to the FDA for epilepsy me...

VBI Vaccinations apply for insolvency, finds asset sale

.Immunology biotech VBI Injections is actually drifting alarmingly near the point of no return, with...